Kyowa Kirin (KYKOF) to Release Quarterly Earnings on Monday

Kyowa Kirin (OTCMKTS:KYKOF) is expected to be issuing its quarterly earnings data before the market opens on Monday, May 5th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $873.75 million for the quarter.

Kyowa Kirin Price Performance

KYKOF stock opened at $14.75 on Friday. The firm has a 50-day moving average price of $13.99 and a 200-day moving average price of $15.09. Kyowa Kirin has a 12 month low of $12.32 and a 12 month high of $22.21.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.